School of Medicine
Showing 1-10 of 14 Results
-
Phillip C. Yang, MD
Professor of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsDr. Yang is a physician-scientist whose research interest focuses on clinical translation of the fundamental molecular and cellular processes of myocardial restoration. His research employs novel in vivo multi-modality molecular and cellular imaging technology to translate the basic innovation in cardiovascular pluripotent stem cell biologics. Dr. Yang is currently a PI on the NIH/NHLBI funded CCTRN UM1 grant, which is designed to conduct multi-center clinical trial on novel biological therapy.
-
Seema Yasmin
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioSeema Yasmin is an Emmy Award-winning journalist, poet, medical doctor and author. Yasmin served as an officer in the Epidemic Intelligence Service at the U.S. Centers for Disease Control and Prevention where she investigated disease outbreaks and was principal investigator on a number of CDC studies. Yasmin trained in journalism at the University of Toronto and in medicine at the University of Cambridge.
Yasmin was a finalist for the Pulitzer Prize in breaking news in 2017 with a team from The Dallas Morning News for coverage of a mass shooting, and recipient of an Emmy for her reporting on neglected diseases. She received multiple grants from the Pulitzer Center on Crisis Reporting for coverage of gender based violence in India and the aftermath of the Ebola epidemic in West Africa. In 2017, Yasmin was a John S. Knight Fellow in Journalism at Stanford University investigating the spread of health misinformation and disinformation during public health crises. Previously she was a science correspondent at The Dallas Morning News, medical analyst for CNN, and professor of public health at the University of Texas at Dallas. She teaches crisis management and crisis communication at the UCLA Anderson School of Management as a Visiting Assistant Professor.
She is the author of eight non-fiction, fiction, poetry and childrens books, including: What the Fact?! Finding the Truth in All the Noise (Simon and Schuster, 2022); Viral BS: Medical Myths and Why We Fall For Them (Johns Hopkins University Press, 2021); Muslim Women Are Everything: Stereotype-Shattering Stories of Courage, Inspiration and Adventure (HarperCollins, 2020); If God Is A Virus: Poems (Haymarket, 2021); Unbecoming: A Novel (Simon and Schuster, 2024); Djinnology: An Illuminated Compendium of Spirits and Stories from the Muslim World (Chronicle, 2024); and The ABCs of Queer History (Workman Books, 2024). Her writing appears in The New York Times, Rolling Stone, WIRED, Scientific American and other outlets.
Yasmin’s unique expertise in epidemics and communications has been called upon by the Vatican, the Presidential Commission for the Study of Bioethical Issues, the Aspen Institute, the Skoll Foundation, the Biden White House, and others. She teaches a new paradigm for trust-building and evidence-based communication to leadership at the World Health Organization and CDC. In 2019, she was the inaugural director of the Stanford Health Communication Initiative.
Her scholarly work focuses on the spread of scientific misinformation and disinformation, information equity, and the varied susceptibilities of different populations to false information about health and science. In 2020, she received a fellowship from the Emerson Collective for her work on inequitable access to health information. She teaches multimedia storytelling to medical students in the REACH program. -
Gwen Yeo
Sr Research Scholar, Medicine - Family & Community Medicine
Current Research and Scholarly InterestsEthnicity and Dementia
Ethnogeriatric Education
Ethnogeriatric Care -
Alan Yeung, MD
Li Ka Shing Professor in Cardiology
Current Research and Scholarly InterestsCoronary artery disease is the leading cause of death in men and women in the United States. Our group is interested in studying both the early and late phases of atherosclerosis so that we can better develop prevention and treatment strategies.
-
Celina Yong, MD, MBA, MSc
Associate Professor of Medicine (Cardiovascular Medicine)
BioCelina Yong, MD, MBA, MSc, FACC, FAHA, FSCAI, is an Associate Professor in the Stanford School of Medicine and Director of Interventional Cardiology at the VA Palo Alto Medical Center. Dr. Yong leads an active health services research program focused on using novel scalable approaches to understand and resolve inequities in cardiovascular care, as well as in the workforce. In her clinical practice, Dr. Yong performs complex coronary and structural procedures and is actively involved in clinical trials of novel device and drug therapies for cardiovascular disease.
Prior to joining the Stanford faculty, Dr. Yong completed an MSc in Health Policy, Planning and Financing from the London School of Economics and MBA from Oxford as a Marshall Scholar. She completed her MD at Stanford, followed by internal medicine residency at University of California, San Francisco and cardiology and interventional cardiology fellowships at Stanford, including serving as Chief Fellow. -
Shady Younis
Instructor, Medicine - Immunology & Rheumatology
BioShady Younis, PhD is an instructor at the division of Immunology and Rheumatology at Stanford University. He received his PhD in Medical Sciences from Uppsala University in Sweden. He later joined Dr. William Robinson’s Lab at Stanford University as Wallenberg postdoctoral fellow, where he characterized the pathogenic role of cytotoxic CD8+ T cells in rheumatoid arthritis. His current research aimed at elucidating the underlying triggers of pathogenic B cell responses in a spectrum of autoimmune diseases, including systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and multiple sclerosis (MS). He uses computational methodologies alongside cutting-edge high-throughput sequencing technologies to characterize the autoreactive B and T cells. The overarching research objective of his research is to unravel the mechanistic roles of Epstein-Barr Virus (EBV) reactivation in activating and transforming autoreactive B cells in the development of autoimmunity.
